New World Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BGCG
Baillie Gifford International Concentrated Growth ETF
BGCG
|
+$9.89M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.25M |
| 3 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.18M |
| 4 |
Microsoft
MSFT
|
+$811K |
| 5 |
NVIDIA
NVDA
|
+$592K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$3.12M |
| 2 |
Meta Platforms (Facebook)
META
|
+$345K |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$230K |
| 4 |
Idexx Laboratories
IDXX
|
+$202K |
| 5 |
Palantir
PLTR
|
+$92.9K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 72.32% |
| 2 | Miscellaneous | 15.81% |
| 3 | Technology | 5.98% |
| 4 | Financials | 1.46% |
| 5 | Communication Services | 1.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
126
Idexx Laboratories
IDXX
$40.5B
| – | – |
-359
| Closed | -$202K |
|
|
127
Vertex Pharmaceuticals
VRTX
$130B
| – | – |
-515
| Closed | -$230K |
|
Similar funds
New World Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, New World Advisors held 127 positions worth $588M, up 3.4% from $569M the previous quarter. Its ten largest holdings account for 90% of the portfolio.
New World Advisors deployed $24M of net new capital in Q2 2026, opening 44 new positions and adding to 58 existing holdings. Its largest new stake was Baillie Gifford International Concentrated Growth ETF: 384,300 shares worth $10.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 72% of assets, down from 79% a quarter earlier, followed by Miscellaneous and Technology.
On the sell side, the largest reduction was TJX Companies, an estimated $3.12M trimmed.
- New World Advisors's largest Q2 2026 buy was Baillie Gifford International Concentrated Growth ETF: 384,300 shares worth $10.1M.
- New World Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $1.25M increase.
- New World Advisors's biggest Q2 2026 reduction was TJX Companies, cutting an estimated $3.12M.
- New World Advisors fully exited Vertex Pharmaceuticals in Q2 2026, selling an estimated $230K.
- New World Advisors's ten largest holdings make up 90% of its $588M portfolio in Q2 2026.
- New World Advisors opened 44 new positions and closed 2 in Q2 2026.
- New World Advisors's portfolio value rose 3.4% quarter-over-quarter to $588M.
Based on New World Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.